Pages that link to "Q73079843"
Jump to navigation
Jump to search
The following pages link to Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation (Q73079843):
Displaying 50 items.
- Therapy-related myeloid neoplasms - what have we learned so far? (Q28071318) (← links)
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms (Q29248394) (← links)
- Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission (Q34102941) (← links)
- The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy (Q34639390) (← links)
- Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients (Q35597072) (← links)
- Subsequent Malignant Neoplasms after Hematopoietic Cell Transplantation (Q35678455) (← links)
- Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature (Q36335336) (← links)
- Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients? (Q36672691) (← links)
- Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road? (Q36858857) (← links)
- Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis (Q36936841) (← links)
- Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party (Q36967098) (← links)
- Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma (Q37103073) (← links)
- Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation (Q37146052) (← links)
- Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AML (Q37173297) (← links)
- Therapy-related myelodysplasia and acute myeloid leukemia (Q37402657) (← links)
- Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients. (Q37548821) (← links)
- What's all the fuss about? facts and figures about bone marrow failure and conditions (Q38039381) (← links)
- Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant? (Q38045706) (← links)
- Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors (Q38093037) (← links)
- Emergence of an unrelated highly aberrant clone in an AML patient at relapse four months after peripheral blood stem cell transplantation (Q38330683) (← links)
- Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis (Q38349205) (← links)
- Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma. (Q38860992) (← links)
- Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study. (Q40465178) (← links)
- Early neutrophil engraftment following autologous BMT provides a functional predictor of long‐term hematopoietic reconstitution (Q40593232) (← links)
- Repetitious appearance and disappearance of different kinds of clonal cytogenetic abnormalities after allogeneic bone marrow transplantation (Q43724883) (← links)
- Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab). (Q43963733) (← links)
- Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma (Q44050414) (← links)
- Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-up (Q44103052) (← links)
- Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer (Q44117851) (← links)
- Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome (Q44399078) (← links)
- Evaluation for the development of 11q23 rearrangements in lymphoma patients treated with a high dose VP-16 and cyclophosphamide salvage regimen (Q44509212) (← links)
- Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma (Q44511397) (← links)
- The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial (Q44557807) (← links)
- Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients (Q44729105) (← links)
- Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow. (Q44851645) (← links)
- Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma (Q45736315) (← links)
- Allogeneic Hematopoietic Stem Cell Transplantation In Therapy-Related Myeloid Neoplasms (t-MN) of the Adult: Monocentric Observational Study and Review of the Literature (Q49233865) (← links)
- Second Malignancies after Hematopoietic Stem Cell Transplantation (Q50104242) (← links)
- Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. (Q53388861) (← links)
- Secondary malignancies and quality of life after stem cell transplantation (Q59538045) (← links)
- High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma (Q60339417) (← links)
- Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1482 patients transplanted in 1990–2003 (Q63583300) (← links)
- Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens (Q73786509) (← links)
- Aggressive hepatocellular carcinoma complicating pregnancy after autologous bone marrow transplantation for non-Hodgkin's lymphoma (Q77649457) (← links)
- Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis (Q79172255) (← links)
- Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study (Q80633278) (← links)
- Numerous nonclonal chromosomal aberrations arising in residual recipient hematopoietic cells following allogeneic bone marrow transplantation (Q81498861) (← links)
- Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis (Q81772364) (← links)
- Management of relapsed diffuse large B-cell lymphoma (Q81789879) (← links)
- A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM (Q89262677) (← links)